Salesforce's Claudeforce Gambit: A 34% Rally Built on Strategy, Substance — and One $2.6 Billion Asterisk
Published on 08/29/2026 at 17:53 | Editorial boerse-global.de
The numbers that lit up Salesforce's stock screen this week tell only part of the story. The rest sits in a partnership announcement that, on its face, looks like a concession: the CRM giant is now embedding its sales tools inside a rival's artificial intelligence.
The move, branded "Claudeforce," positions Salesforce as a plugin within Anthropic's Claude ecosystem, shipping with 37 pre-built sales functions. Pilot customers already have access, an open beta lands in September, and additional capabilities are slated for year-end. For a company that spent decades positioning its own platform as the center of its customers' software universe, this is a notable strategic shift — one that signals a willingness to meet users wherever they're already talking to AI, even if that means operating inside someone else's model.
The market's response was emphatic. Salesforce shares surged roughly 22 percent in a single session following the earnings release and Anthropic expansion — the stock's strongest one-day rally since 2020, according to Bloomberg. In Frankfurt, the shares closed Friday at EUR 221.00, up 2.1 percent on the day alone. Over the past seven trading sessions, the gain compounds to 23 percent; over 30 days, it reaches 34 percent.
The Earnings Behind the Euphoria
For the second quarter of fiscal 2027, Salesforce reported revenue of $11.35 billion, with adjusted earnings per share of $5.90 and net income of $3.53 billion. The company also raised its full-year revenue outlook to a range of $46.1 billion to $46.4 billion, up from a prior $45.9 billion to $46.2 billion. For the third quarter, management guided to revenue between $11.42 billion and $11.50 billion.
But the headline EPS figure deserves a closer look. A $2.6 billion book gain from Salesforce's strategic stake in Anthropic flowed into the results. Strip that out, and adjusted EPS lands closer to $3.37 — still up roughly 16 percent year over year, but a far cry from the doubling the raw number suggests. The operational picture, however, remains sturdy: operating cash flow climbed 71 percent to $1.3 billion, free cash flow rose 81 percent to $1.1 billion, and current remaining performance obligations (cRPO) grew 14 percent to $33.5 billion — a metric less distorted by accounting effects and arguably a cleaner read on demand.
Should investors sell immediately? Or is it worth buying Salesforce?
Shareholder returns continue apace: $364 million went out in dividends, alongside an accelerated $25 billion share buyback program.
Agentforce Grows Into a Revenue Driver
The second AI narrative running through the quarter is Agentforce. Speaking at the Deutsche Bank Technology Conference, Salesforce disclosed that annualized recurring revenue for Agentforce now sits at nearly $3.9 billion — roughly on par with Data 360. Combined, the two AI product lines grew 210 percent year over year to $3.9 billion in annualized revenue, with Agentforce alone surpassing $1.5 billion.
Those growth rates are striking, though they start from a base that remains modest relative to the company's roughly $46 billion in projected annual revenue. Still, the scale signals that the AI agent strategy has graduated from pilot project to a legitimate revenue contributor.
A Sector-Wide Tailwind
Salesforce's pop didn't happen in a vacuum. CrowdStrike gained more than 20 percent after its own record results, Workday added nearly 6 percent, and ServiceNow drew multiple price-target hikes. The IGV software index notably outperformed the broader tech market. For some observers, this suggests the long-feared "SaaS apocalypse" has been called off — at least for now. Even prominent skeptics like Chamath Palihapitiya, who months ago dismissed the RPO concept as worthless, have softened their stance on software valuations.
The Technical Picture Warrants Caution
For all the enthusiasm, the charts flash warning signals. The relative strength index sits at 80.5 — firmly in overbought territory. The share price now trades 40 percent above its 50-day moving average, an unusually stretched gap. And despite the recent surge, the stock remains 3.9 percent below its 52-week high of EUR 229.90, set on October 21, 2025. Year to date, shares are still down 2.5 percent, underscoring how much ground the recent rally has had to reclaim.
Two Stories, One Ticker
What's driving the move — the Anthropic narrative or the operational improvement? The honest answer is both, and they're difficult to disentangle. The book gain from the Anthropic stake inflates the earnings figure, but the partnership itself is a strategic bet that Salesforce's tools should live wherever customers are already working. Whether that's a capitulation to an unstoppable competitor or the smartest response to a shifting software landscape won't be clear until the September beta produces real usage data.
For now, the market has chosen to reward the story. But investors projecting the last 30 days forward should remember: a meaningful slice of this quarter's earnings magic was a one-time accounting effect, not a recurring operational result. The underlying business is solid — growing backlog, strong cash generation, triple-digit AI growth — yet the most spectacular part of the profit figure is, by definition, not repeatable.
Ad
Salesforce Stock: New Analysis - 29 August
Fresh Salesforce information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
